Participated · Seed · Feb 2026

AironWorks is building an enterprise cybersecurity platform that tackles the growing wave of generative-AI-enabled spear-phishing and social-engineering threats. Its multi-layered solution combines highly realistic phishing simulations, just-in-time micro-training, an always-on AI assistant for employees, and automated detection that blocks attacks before they spread. The company operates across Japan and Israel, two markets with deep cybersecurity talent pools, and intentionally bridges expertise from both regions. Investors say AironWorks’ approach prepares workforces while simultaneously hardening technical defenses, creating a full-cycle response to human-centric cyber risks. Earlier backing from Salesforce Ventures, SBI, and All Star SaaS Fund has now been supplemented by new institutional supporters. With its latest capital, the team plans to accelerate product development and expand enterprise reach. Although the firm has not disclosed revenue or user counts, the $13 million seed round marks a significant step toward scaling its offering.

Participated · Series F · Jan 2026

Rakuten Medical, founded in 2010 and headquartered in San Diego, develops photoimmunotherapy using its Alluminox® platform, which combines targeted drug conjugates and light-delivery devices. Its lead asset, ASP-1929 (an antibody-dye conjugate using cetuximab and IRDye® 700DX), is approved in Japan for unresectable locally advanced or recurrent head and neck cancer and is being evaluated outside Japan. ASP-1929 is currently in a global Phase 3 trial in combination with pembrolizumab as a first-line treatment for recurrent head and neck cancer, with the company aiming to generate pivotal data to support a planned BLA submission to the U.S. FDA in 2028. Rakuten Medical is enrolling patients across the U.S., Japan, Taiwan, and Ukraine, with Poland sites expected to activate soon. The company is expanding its pipeline through internal programs and investigator-initiated trials, and plans a Phase 1 study of RM-0256 in Japan expected to begin in Q2 2026 with Japanese government grant support. Rakuten Medical operates offices in the United States, Japan, Taiwan, Switzerland and India and continues to grow its commercial presence in Japan to support global expansion.

Participated · Equity · Jul 2024

KINS is a microbiome-focused healthcare company that researches, develops, and sells products based on proprietary bacteria, including recently acquired polyamine-producing lactic acid strains. Its core offerings span consumer products (20+ SKUs) and clinic services, supported by a proprietary bacterial bank of over ~20,000 human skin specimens. The firm reports more than 100,000 cumulative users and operates two animal hospitals in Japan and one human clinic in Singapore. KINS is advancing R&D into microbiome drug seeds while preparing probiotic products and bacterial raw materials for commercial sale. The company is investing in research capability (hiring, lab expansion, equipment), PR and organizational buildout to commercialize its bacteria across B2C and B2B channels. It also plans to strengthen consumer sales via its own e-commerce and marketplace channels and to pursue joint-development and distribution partnerships with strategic corporate partners.

Participated · Series C · Apr 2023

hacomono builds an all-in-one core system for subscription wellness businesses, digitizing membership, bookings, and payments to improve customer experience. The company began offering the hacomono system in March 2019 and has expanded beyond fitness clubs into schools and public sports facilities. Its platform is used by over 3,000 stores and more than 3.1 million customers. The startup recently completed equity and debt financings that increased its cumulative funding to ¥6.45 billion. Proceeds are earmarked to accelerate product development, leverage IoT, and conduct hardware R&D to speed store DX. The company also plans investments in new businesses including FinTech, plus hiring and organizational strengthening to expand cashless adoption and support regional wellness initiatives.

Led · Series A · Apr 2022

Leal is a SaaS retail-tech company that enables B2C brands, e-commerce sites and financial institutions to build customer databases and offer cashback, rewards and targeted campaign management. The platform integrates with 160 point-of-sale systems and provides campaign tools and customer-behavior tracking, including for cash-paying customers. Leal works with more than 1,000 brands across 15 industries in eight countries; its client list includes Subway, Verifone and Chevron. The company reports more than 6 million users (up from 1.5 million in 2020), with 3.5 million active users joining in the last 12 months. Founded in 2016 by Camilo Martinez and Florence Frech and based in Bogotá, Leal nearly lost 85% of its merchants during the pandemic and rebuilt its business from 2021 onward. With the new funding it plans to reach $10 million in annual recurring revenue and to invest in Mexico penetration, omnichannel communications, smarter data collection, automation of benefits and AI-driven personalization including generative-AI chatbots and strengthened WhatsApp and Facebook Messenger channels. Leal is a Bogota, Colombia-based fintech operating across Latin America that provides cashback and rewards products enabling consumers to earn money back on everyday purchases. Led by CEO Camilo Martinez and COO Florence Frech, Leal launched in 2021 functionality that lets grocery shoppers scan paper receipts to earn Leal Coins redeemable for goods and services including gas, cell phone top-ups and Rappi deliveries. The company positions its digital wallet as an ecosystem that offers additional services beyond cashback, including a broader payment ecosystem and merchant network. Leal plans to expand its rewards program, digital wallet, payment ecosystem, user base, merchant network and Leal Coins throughout Mexico, Colombia and Central America in 2022. It intends to use new funding to launch a co-branded credit card, scale operations in Mexico and invest in technology development over the next year. Leal is a loyalty startup based in Bogota that aggregates reward programs into a single app used by more than 1 million registered users and over 450 affiliated brands. The platform integrates with point-of-sale payment terminals to capture transactional data and convert it into analytics for merchants. Businesses can use Leal's analytics to identify customers, visit frequency, average purchase tickets and brand perception. The system also enables brands to send customized, automated messages via SMS or email. Leal intends to use the new funding to accelerate expansion into Central America, starting with El Salvador and Panama. Co-founded by Florence Frech and Camilo Martinez, the company has raised more than US$5m to date.